TGTGInsightтелеграм анализLIVE / telegram public index
← Такты, стеки, два колеса

TGINSIGHT SIMILAR POSTS

Намери подобно съдържание

Изходен канал @clockstackwheels · Post #950 · 2.02

Мысли за январь вышли объёмными. Видимо, в период праздников я думаю больше, чем на работе. О парадоксе USB и вреде VR, о плохих водителях, удивительных совпадениях, неграмотных людях и многом другом. #thoughts https://telegra.ph/Mysli-za-yanvar-02-02

Hashtags

Резултати

Намерени 3 подобни публикации

Търсене: #genetherapy

当前筛选 #genetherapy清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3846 · 11.01.2025 г., 10:00

Funding Rounds Boost Healthcare & Energy Sectors Several companies have recently secured significant funding: - Arizona Public Service: $1.81B, Jan 8, 2025. - Nephron Pharmaceuticals: $350M, Jan 10, 2025. - Windward Bio: $200M, Jan 10, 2025. - Timberlyne Therapeutics: $180M, Jan 10, 2025. - Hippocratic AI: $141M, Jan 9, 2025. - Ouro Medicines: $120M, Jan 10, 2025. - Movement Labs: $100M, Jan 8, 2025. - Rhygaze: $86M, Jan 10, 2025. - Light Horse Therapeutics: $62M, Jan 9, 2025. - Overhaul: $55M, Jan 10, 2025. - Numab: $54.94M, Jan 9, 2025. - Harsoria Healthcare: $20M, Jan 9, 2025. - Huazhi Energy: $13.64M, Jan 8, 2025. - Lava Network: $12M, Jan 9, 2025. - Pakistan Refinery Ltd: $11.24M, Jan 8, 2025. Find detailed updates on respective company websites for more insights. #Funding#Healthcare#Biotech#Energy#Pharmaceuticals#AI#Tech#GeneTherapy#Blockchain#VentureCapital#Investment

Venture Village Wall 🦄

@venturevillagewall · Post #3391 · 18.12.2024 г., 12:09

Concinnity Genetics Secures $3.79M Concinnity Genetics has raised $3.79 million in funding as of December 16, 2024. The company specializes in RNA-based gene control systems, aimed at enhancing the precision and safety of gene therapies. #Funding#GeneTherapy#RNA#ConcinnityGenetics#Biotech#Healthcare#Innovation

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 18.12.2024 г., 12:11

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform